Patents by Inventor Mark E. Peterson

Mark E. Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200178577
    Abstract: A process for preparing a galacto-oligosaccharide product comprises exposing a permeate composition to one or more enzymes that convert one or more compounds in the permeate composition to one or more galacto-oligosaccharide compounds to provide a galacto-oligosaccharide solution, wherein at least about 10% of total sugar, by weight, in the galacto-oligosaccharide solution is in the form of the one or more galacto-oligosaccharide compounds, and concentrating at least a portion of the galacto-oligosaccharide solution to provide a galacto-oligosaccharide syrup. In an example, a galacto-oligosaccharide product, for example made by the process, comprises a dry or substantially dry powder including one or more dried compounds from a permeate composition and at least 20% by weight of one or more galacto-oligosaccharides, wherein the powder is free or substantially free from a drying agent.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 11, 2020
    Inventors: Zahid Mozaffar, Mark E. Peterson
  • Publication number: 20180007937
    Abstract: A process for preparing a galacto-oligosaccharide product comprises exposing a permeate composition to one or more enzymes that convert one or more compounds in the permeate composition to one or more galacto-oligosaccharide compounds to provide a galacto-oligosaccharide solution, wherein at least about 10% of total sugar, by weight, in the galacto-oligosaccharide solution is in the form of the one or more galacto-oligosaccharide compounds, and concentrating at least a portion of the galacto-oligosaccharide solution to provide a galacto-oligosaccharide syrup. In an example, a galacto-oligosaccharide product, for example made by the process, comprises a dry or substantially dry powder including one or more dried compounds from a permeate composition and at least 20% by weight of one or more galacto-oligosaccharides, wherein the powder is free or substantially free from a drying agent.
    Type: Application
    Filed: July 6, 2017
    Publication date: January 11, 2018
    Inventors: Zahid Mozaffar, Mark E. Peterson
  • Patent number: 6165776
    Abstract: Esculin-free hemolytic Ceftazidime lithium chloride agar (HCLA) as a selective and differential medium specific for the isolation of Listeria monocytogenes. The medium also contains red blood cells.
    Type: Grant
    Filed: March 30, 1994
    Date of Patent: December 26, 2000
    Assignee: The United States of America as represented by the Secretary of Commerce
    Inventors: Mel W. Eklund, Frank T. Poysky, Rohinee N. Paranjpye, Laura C. Lashbrook, Mark E. Peterson, Gretchen A. Pelroy